Canopy Growth Corp income statement CGC

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
Q4 FY2026
Mar 31, 2026
Q3 FY2026
Dec 31, 2025
Q2 FY2026
Sep 30, 2025
Q1 FY2026
Jun 30, 2025
Q4 FY2025
Mar 31, 2025
Q3 FY2025
Dec 31, 2024
Q2 FY2025
Sep 30, 2024
Q1 FY2024
Jun 30, 2024
Weighted average shares, basic
385
+149.2%
346
+213.3%
274
+215.6%
188
154
110
87
79
+44.0%
Weighted average shares, diluted
385
+149.2%
346
+213.3%
274
+215.6%
188
154
110
87
79
+44.0%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CGC (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Canada (Federal Level)
Headquarters
Smith Falls, Ontario, Canada
SEC filer status
Accelerated filer
SEC CIK
1737927

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.